Multiple endocrine neoplasia type 1: latest insights
ML Brandi, SK Agarwal, ND Perrier, KE Lines… - Endocrine …, 2021 - academic.oup.com
Multiple endocrine neoplasia type 1 (MEN1), a rare tumor syndrome that is inherited in an
autosomal dominant pattern, is continuing to raise great interest for endocrinology …
autosomal dominant pattern, is continuing to raise great interest for endocrinology …
Cushing's syndrome
Chronic exposure to excess glucorticoids results in diverse manifestations of Cushing's
syndrome, including debilitating morbidities and increased mortality. Genetic and molecular …
syndrome, including debilitating morbidities and increased mortality. Genetic and molecular …
Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement
FF Casanueva, AL Barkan, M Buchfelder, A Klibanski… - Pituitary, 2017 - Springer
Introduction With the goal of generate uniform criteria among centers dealing with pituitary
tumors and to enhance patient care, the Pituitary Society decided to generate criteria for …
tumors and to enhance patient care, the Pituitary Society decided to generate criteria for …
The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new
P Chanson, D Maiter - Best practice & research Clinical endocrinology & …, 2019 - Elsevier
Prevalence and incidence of prolactinomas are approximately 50 per 100,000 and 3–5 new
cases/100,000/year. The pathophysiological mechanism of hyperprolactinemia-induced …
cases/100,000/year. The pathophysiological mechanism of hyperprolactinemia-induced …
Incidence of pituitary adenomas in Northern Finland in 1992–2007
A Raappana, J Koivukangas, T Ebeling… - The Journal of Clinical …, 2010 - academic.oup.com
Context: Data on the incidence of pituitary adenomas (PAs) are scant and outdated. A
population-based regional cohort with thorough case identification was used to evaluate the …
population-based regional cohort with thorough case identification was used to evaluate the …
Management of dopamine agonist-resistant prolactinoma
D Maiter - Neuroendocrinology, 2019 - karger.com
Dopamine agonists are usually very effective in the treatment of prolactinomas.
Nonetheless, a subset of individuals does not respond satisfactorily to these agents, and this …
Nonetheless, a subset of individuals does not respond satisfactorily to these agents, and this …
Prevalence and incidence of pituitary adenomas: a population based study in Malta
M Gruppetta, C Mercieca, J Vassallo - Pituitary, 2013 - Springer
Epidemiological data is important to correctly quantify the extent of disease and needed
health care resources. The aim of the study was to establish the prevalence and incidence of …
health care resources. The aim of the study was to establish the prevalence and incidence of …
Pituitary carcinoma: difficult diagnosis and treatment
AP Heaney - The Journal of Clinical Endocrinology & …, 2011 - academic.oup.com
Context: Although pituitary tumors are common, pituitary carcinoma is very rare and is only
diagnosed when pituitary tumor noncontiguous with the sellar region is demonstrated …
diagnosed when pituitary tumor noncontiguous with the sellar region is demonstrated …
Novel genetic causes of pituitary adenomas
F Caimari, M Korbonits - Clinical Cancer Research, 2016 - AACR
Recently, a number of novel genetic alterations have been identified that predispose
individuals to pituitary adenomas. Clinically relevant pituitary adenomas are relatively …
individuals to pituitary adenomas. Clinically relevant pituitary adenomas are relatively …
[HTML][HTML] Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study
N Majd, SG Waguespack, F Janku, S Fu… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Pituitary carcinoma is an aggressive tumor characterized by metastatic spread beyond the
sellar region. Symptoms can be debilitating due to hormonal excess and survival is poor …
sellar region. Symptoms can be debilitating due to hormonal excess and survival is poor …